News & Trends - Biotechnology
‘Innovation makes a real and measurable difference to people’s lives at their most vulnerable time’, says Noxopharm CEO: National Science Week
Biotech News: Embarking on the next chapter of our interview series celebrating National Science Week, Dr Gisela Mautner, CEO and Managing Director of Australian biotech company Noxopharm delved into the intersection between innovation and the dynamic healthcare landscape.
At the heart of our conversation was the National Science Week theme, Innovation: Powering Future Industries. Dr Mautner’s articulation of her personal passion for STEM underscored the profound alignment between her dedication and the overarching theme.
“Innovation in the development of new technologies is absolutely central to bridging the gaps that we have in the current healthcare system, to be able to improve patients’ lives. This is why I’m so excited about STEM as it’s a relentless push of current boundaries. I feel it makes a real and measurable difference to people’s lives, and specifically to people’s lives at their most vulnerable time when they’re sick,” she stated.
Turning our attention to recent events, Dr Mautner shared the key highlights from the BIO International Convention. These highlights seamlessly converged with Noxopharm’s pioneering research pursuits, underscoring the organisation’s commitment to steering healthcare innovation toward new horizons.
Anticipating the future, Dr Mautner shared her perspectives on the forthcoming RNA Leaders Congress in Boston. Her observations regarding the conference’s alignment with the National Science Week theme emphasised the enduring impact of innovation as an enabler of progress within healthcare.
In reflecting upon the year so far, Dr Mautner shared a thoughtful evaluation of the accomplishments that resonate most profoundly. Her insights unveil strategic milestones that underscore Noxopharm’s pivotal contribution to shaping the trajectory of innovation in healthcare.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics
AI-assisted colonoscopy boosts polyp and adenoma detection
MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]
MoreNews & Trends - Pharmaceuticals
‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO
Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]
MoreNews & Trends - Pharmaceuticals
Government’s silence on Senate report leaves cancer patients in limbo
Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]
More